MarketsStocksMOREPENLAB
MO

Morepen Laboratories Ltd

NSE: MOREPENLABBSE: 500288Healthcare
Download Research Report7-page PDF
42.60
-2.63%
NSE · auto-updates while market open
Prev Close
₹64.12
Day High
₹44.44
Day Low
₹42.50
Mkt Cap
₹2,324 Cr
P / E
24.5
P / B
1.9
ROE
7.9%
52W High
₹70.50
52W Low
₹33.05
Key Metrics
Market Cap
₹2,324 Cr
P / E
24.50
P / B
1.86
EV / EBITDA
16.66
ROCE
10.2%
ROE
7.9%
Debt / Equity
0.16
Book Value
₹22.75
EPS
₹1.73
Div Yield
0.5%
Face Value
₹2
Promoter Holding
35.6%
Revenue · ₹ Cr
853
FY20
1.2k
FY21
1.5k
FY22
1.4k
FY23
1.7k
FY24
1.8k
FY25
1.8k
FY26
Net Profit · ₹ Cr
34
FY20
97
FY21
102
FY22
39
FY23
96
FY24
118
FY25
95
FY26
EPS · ₹ per share
₹0.8
FY20
₹2.2
FY21
₹2.3
FY22
₹0.8
FY23
₹1.9
FY24
₹2.2
FY25
₹1.7
FY26
P / E Ratio · price ÷ TTM EPS
11254054310-0Jun 21Feb 23Oct 24Jun 26
P/E 24.8×Median 26.6×TTM EPS
Q1 2026 snapshot
Sales
₹493 Cr
Operating profit
-
OPM
-
Net profit
₹16 Cr
EPS
₹0.28
Scorecard · 7 axes
Quality
Avg
46/100
Valuation
Good
24.5×
Growth
Weak
+1.1%
Profitability
Weak
9.0%
Performance
Bad
-32.1%
Entry Point
Good
60%
Red Flags
Strong
0 flags
Shareholding Pattern
35.6%Promoter
Promoter35.6%
FII1.6%
DII1.3%
Public61.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue452.781470.46429.65416.21487.97493.18
Net Profit26.68920.31510.74840.87527.50915.745
NPM %5.9%4.3%2.5%9.8%5.6%3.2%
AlertPre-trade